Summary: <p>In the UK chronic gastrointestinal symptoms after cancer therapies have a similar impact as IBD. However, in contrast to patients with IBD, most of these patients won’t see a gastroenterologist. In this month’s Gut Editor’s Choice the causes of these side effects of cancer treatment are discussed, as well as the benefits of investigation and treatment.</p><p>In this podcast Mairi McLean, senior clinical lecturer and consultant in gastroenterology at the University of Aberdeen talks to some key stakeholders in this issue:</p><p>Professor Sir Mike Richards, national clinical director for cancer and end of life care, Department of Health</p><p>Jane Maher, chief medical officer for McMillian Cancer Support</p><p>Jon Rhodes, professor of gastroenterology and president of the British Society of Gastroenterology</p><p>Jervoise Andeyev, consultant gastroenterologist in pelvic radiation disease at the Royal Marsden NHS Trust, London</p><p>See also:</p><p>Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer (http://tinyurl.com/a6krvl8)</p>
